Navigation Links
PRA Named "Clinical Company of the Year" in National Contest for Second Year
Date:11/20/2013

RALEIGH, N.C., Nov. 20, 2013 /PRNewswire/ -- PRA, a leading clinical research organization, today announced it has won the 2013 U.S. Clinical Researcher of the Year's "Clinical Company of the Year" award for the second consecutive year, as well as several individual honors at the competition's finals ceremony held recently in Cary, NC. Included in PRA's individual winners was a clean sweep of the Project Management category, where PRA claimed first, second, and third place.

Organized by PharmaTimes, the event named PRA "Clinical Company of the Year" based on the total points earned by its employees' performances in individual competitions. Fourteen PRA employees across four categories were invited to attend the in-person finals competition. They competed with nearly 200 other contestants in a rigorous three-phase process that tested their skills in risk-based monitoring and virtual teamwork.

"This contest allows our employees to compete against other talented professionals in the clinical research industry," said PRA Executive Vice President of Product Registration-Americas, Andrew Strayer. "Being named 'Clinical Company of the Year' for the second year in a row is an achievement that speaks to the level of commitment and dedication of our employees."

PRA employees earning this year's awards include: Lee Steen, second place, New Clinical Research Associate category; Promise Lawrence, first place, Project Manager category; Sarah Connell, second place, Project Manager category; and Adrienne Stoudenmire, third place, Project Manager category.

About PRA

One of the world's largest CROs, PRA is transforming clinical trials through our people, innovation and operational transparency. Our 10,000+ employees operate in more than 80 countries, delivering a broad spectrum of full-service and Embedded clinical trial solutions that meet the demands of a diverse marketplace.

PRA's Early Development Services group is committed to the highest standards of clinical excellence and scientific expertise. We operate state-of-the-art facilities in The Netherlands and North America as well as an innovative patient pharmacology model in Central and Eastern Europe providing the pharmaceutical and biotech industries with the unique scientific environment required for complex compound development and testing. In addition, PRA's harmonized laboratory facilities in The Netherlands and the US are situated close to the clinical facilities and are configured to fully support all clinical study requirements.

Over the last 30+ years, PRA has established a reputation for specialized expertise and success in a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. Our forward-thinking approach to clinical research innovation, customized recruitment strategies and technological advances continues to make a difference to healthcare patients around the world.

To learn more about PRA, please visit praintl.com, email clearlypra@praintl.com.


'/>"/>
SOURCE PRA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vasomedical Again Named on Deloittes Technology Fast 500 List
2. Edith Sanford Breast Cancer Foundation Named Official Charity Partner of Womens Running Series
3. ISPE Named as a Source in FDA Strategic Plan for Preventing and Mitigating Drug Shortages
4. PRA Staff Named Finalists in Clinical Researcher of the Year Competition
5. AbbVie Named a Science Top Employer
6. BioTrackTHC Named Washington States Legal Marijuana Traceability System
7. United Spinal Named Beneficiary Of Permobils 3rd Annual Charity Golf Tournament
8. XYMOGEN Named Among The Nations Fastest Growing Private Companies For The Sixth Time
9. PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time
10. Philadelphia Business Journal has named Hope Paige Medical ID one of its Best Places to Work in Philadelphia
11. USANA Named One Of Americas Best Places To Work By Outside Magazine For 5th Consecutive Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... 13, 2017 , ... Lori R. Somekh, founder of the Law Office ... of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office ... forum to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
Breaking Medicine News(10 mins):